Novel MEIS1 target genes: Insights on molecular pathways in acute myeloid leukemia

被引：0
|
作者：
Argiropoulos, B.
Yung, E.
Palmqvist, L.
Humphries, R. K.
机构：
[1] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[2] Sahlgrens Univ Hosp, Inst Biomed, S-41345 Gothenburg, Sweden
来源：
EXPERIMENTAL HEMATOLOGY | 2007年 / 35卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] MEIS1 and HOXA7 genes in human acute myeloid leukemia
    Afonja, O
    Smith, JE
    Cheng, DM
    Goldenberg, AS
    Amorosi, E
    Shimamoto, T
    Nakamura, S
    Ohyashiki, K
    Ohyashiki, J
    Toyama, K
    Takeshita, K
    LEUKEMIA RESEARCH, 2000, 24 (10) : 849 - 855
  • [2] Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia
    Thorsteinsdottir, U
    Kroon, E
    Jerome, L
    Blasi, F
    Sauvageau, G
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (01) : 224 - 234
  • [3] The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia
    Arabanian, Laleh S.
    Johansson, Pegah
    Staffas, Anna
    Nilsson, Tina
    Rouhi, Arefeh
    Fogelstrand, Linda
    Palmqvist, Lars
    LEUKEMIA RESEARCH, 2018, 75 : 61 - 68
  • [4] Evaluation of the HOXA9 and MEIS1 genes as a potential biomarker in adult acute myeloid leukemia
    Amira M. N. Abdelrahman
    Fetnat Mahmoud Tolba
    Howyda Mohamed Kamal
    Mona S. Abdellateif
    Heba Abdelmoneim Ahmed
    Naglaa M. Hassan
    Egyptian Journal of Medical Human Genetics, 24
  • [5] Evaluation of the HOXA9 and MEIS1 genes as a potential biomarker in adult acute myeloid leukemia
    Abdelrahman, Amira M. N.
    Tolba, Fetnat Mahmoud
    Kamal, Howyda Mohamed
    Abdellateif, Mona S.
    Ahmed, Heba Abdelmoneim
    Hassan, Naglaa M.
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2023, 24 (01)
  • [6] Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia
    Schneider, Edith
    Staffas, Anna
    Roehner, Linda
    Malmberg, Erik D.
    Ashouri, Arghavan
    Krowiorz, Kathrin
    Pochert, Nicole
    Miller, Christina
    Wei, Stella Yuan
    Arabanian, Laleh
    Buske, Christian
    Doehner, Hartmut
    Bullinger, Lars
    Fogelstrand, Linda
    Heuser, Michael
    Doehner, Konstanze
    Xiang, Ping
    Ruschmann, Jens
    Petriv, Oleh I.
    Heravi-Moussavi, Alireza
    Hansen, Carl L.
    Hirst, Martin
    Humphries, R. Keith
    Rouhi, Arefeh
    Palmqvist, Lars
    Kuchenbauer, Florian
    HAEMATOLOGICA, 2018, 103 (02) : 246 - 255
  • [7] MEIS1 is a promising new target for leukemia therapy
    Kumar, Ashish
    Li, Quanzhi
    Chen, Weili
    Hudson, Wendy A.
    Kersey, John H.
    BLOOD, 2007, 110 (11) : 267A - 267A
  • [8] Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression
    Juul-Dam, Kristian L.
    Shukla, Neerav N.
    Cooper, Todd M.
    Cuglievan, Branko
    Heidenreich, Olaf
    Kolb, E. Anders
    Rasouli, Milad
    Hasle, Henrik
    Zwaan, Michel
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2023, 66 (12)
  • [9] A novel engineered dominant silencing form of MEIS1 suppresses HOX-mediated acute myeloid leukemia
    Argiropoulos, B.
    Palmqvist, L.
    Yung, E.
    Goh, S.
    Featherstone, M.
    Humphries, K.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 27 - 28
  • [10] Identification of meis1 as a target of CREB in myeloid leukemogenesis.
    Esparza, Samuel D.
    Shankar, Deepa
    Nelson, Stanley
    Sakamoto, Kathleen
    BLOOD, 2006, 108 (11) : 550A - 550A
12345